Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,069 | -28,916 | N/A | N/A | N/A |
| Depreciation Amortization | 819 | 309 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 317 | 841 | N/A | N/A | N/A |
| Other Working Capital | -1,770 | 3,034 | N/A | N/A | N/A |
| Other Operating Activity | 2,010 | 830 | 0 | 0 | 0 |
| Operating Cash Flow | $-30,693 | $-23,902 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -54 | N/A | N/A | N/A |
| Purchase Of Investment | -18,945 | -20,179 | N/A | N/A | N/A |
| Sale Of Investment | 29,957 | 42,257 | N/A | N/A | N/A |
| Investing Cash Flow | $10,955 | $22,024 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,704 | 98 | N/A | N/A | N/A |
| Other Financing Activity | -9,607 | -61 | 0 | 0 | 0 |
| Financing Cash Flow | $11,097 | $37 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 23,443 | 25,284 | N/A | N/A | N/A |
| End Cash Position | 14,802 | 23,443 | N/A | N/A | N/A |
| Net Cash Flow | $-8,641 | $-1,841 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,693 | -23,902 | N/A | N/A | N/A |
| Capital Expenditure | -57 | -54 | N/A | N/A | N/A |
| Free Cash Flow | -30,750 | -23,956 | 0 | 0 | 0 |